CCA
BLFS icon

Conestoga Capital Advisors’s BioLife Solutions BLFS Stock Holding History

Conestoga Capital Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
121,652
+29,180
+32% +$682K 0.07% 66
2026
Q1 		$1.76M Buy
92,472
+13,980
+18% +$309K 0.04% 70
2025
Q4 		$1.9M Buy
78,492
+2,990
+4% +$78.2K 0.03% 66
2025
Q3 		$1.93M Buy
75,502
+10,485
+16% +$249K 0.03% 71
2025
Q2 		$1.4M Hold
65,017
– – 0.02% 79
2025
Q1 		$1.48M Hold
65,017
– – 0.02% 74
2024
Q4 		$1.69M Sell
65,017
-220
-0.3% -$5.47K 0.02% 73
2024
Q3 		$1.63M Hold
65,237
– – 0.02% 70
2024
Q2 		$1.4M Sell
65,237
-240
-0.4% -$4.66K 0.02% 77
2024
Q1 		$1.21M Buy
65,477
+630
+1% +$11K 0.02% 87
2023
Q4 		$1.05M Buy
64,847
+2,585
+4% +$33K 0.02% 94
2023
Q3 		$860K Hold
62,262
– – 0.01% 95
2023
Q2 		$1.38M Sell
62,262
-10,665
-15% -$225K 0.02% 75
2023
Q1 		$1.59M Hold
72,927
– – 0.03% 71
2022
Q4 		$1.33M Hold
72,927
– – 0.02% 77
2022
Q3 		$1.66M Sell
72,927
-8,620
-11% -$184K 0.03% 74
2022
Q2 		$1.13M Buy
81,547
+24,182
+42% +$355K 0.02% 88
2022
Q1 		$1.3M Buy
57,365
+5,655
+11% +$149K 0.02% 90
2021
Q4 		$1.93M Buy
51,710
+9,300
+22% +$399K 0.03% 80
2021
Q3 		$1.79M Sell
42,410
-8,100
-16% -$390K 0.02% 84
2021
Q2 		$2.25M Buy
50,510
+1,125
+2% +$39.6K 0.03% 80
2021
Q1 		$1.78M Hold
49,385
– – 0.03% 85
2020
Q4 		$1.97M Sell
49,385
-6,150
-11% -$210K 0.03% 76
2020
Q3 		$1.61M Buy
55,535
+2,550
+5% +$55.1K 0.03% 76
2020
Q2 		$866K Buy
52,985
+22,425
+73% +$309K 0.02% 95
2020
Q1 		$290K Buy
30,560
+750
+3% +$10.3K 0.01% 124
2019
Q4 		$482K Buy
29,810
+15,425
+107% +$251K 0.01% 115
2019
Q3 		$239K Buy
14,385
+575
+4% +$10.8K 0.01% 137
2019
Q2 		$234K Buy
13,810
+490
+4% +$8.54K 0.01% 141
2019
Q1 		$238K Buy
+13,320
New +$212K 0.01% 137

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Conestoga Capital Advisors's BLFS Position: Q2 2026 in Review

Conestoga Capital Advisors increased its BioLife Solutions (BLFS) stake by 32% in Q2 2026, buying an estimated $682K and bringing the position to 121,652 shares worth $3.44M. The position accounts for 0.07% of the portfolio, ranked #66.

Conestoga Capital Advisors first reported a position in BLFS in Q1 2019 and has held it in 30 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Conestoga Capital Advisors held 121,652 shares of BioLife Solutions worth $3.44M as of Q2 2026.
  • Conestoga Capital Advisors bought 29,180 BioLife Solutions shares in Q2 2026, an estimated $682K.
  • BioLife Solutions made up 0.07% of Conestoga Capital Advisors's portfolio in Q2 2026, its #66 holding.
  • Conestoga Capital Advisors first reported a position in BioLife Solutions in Q1 2019 and has held it in 30 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.